Cargando…

Prodrugs of γ‐Alkyl‐Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase

The development of nucleoside triphosphate prodrugs is one option to apply nucleoside reverse transcriptase inhibitors. Herein, we report the synthesis and evaluation of d4TTP analogues, in which the γ‐phosphate was modified covalently by lipophilic alkyl residues, and acyloxybenzyl prodrugs of thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chenglong, Weber, Stefan, Schols, Dominique, Balzarini, Jan, Meier, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756582/ https://www.ncbi.nlm.nih.gov/pubmed/32379948 http://dx.doi.org/10.1002/anie.202003073

Ejemplares similares

Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals
por: Gollnest, Tristan, et al.
Publicado: (2015)

Nucleoside diphosphate and triphosphate prodrugs – An unsolvable task?
por: Meier, Chris
Publicado: (2017)

γ‐Non‐Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV
por: Zhao, Chenglong, et al.
Publicado: (2020)

The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors
por: Fernandes, Lívia da Rocha, et al.
Publicado: (2023)

Modified nucleoside triphosphates exist in mammals
por: Jiang, Han-Peng, et al.
Publicado: (2018)

Modified Nucleoside Triphosphates for In-vitro Selection Techniques
por: Dellafiore, María A., et al.
Publicado: (2016)

Synthesis and Evaluation of Prodrugs of α-Carboxy Nucleoside Phosphonates
por: Ford, Alan, et al.
Publicado: (2022)

Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants
por: Shakil, Anika, et al.
Publicado: (2022)

Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs
por: Pileggi, Elisa, et al.
Publicado: (2018)

NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
por: Thammaporn, Ratsupa, et al.
Publicado: (2015)

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2016)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
por: Wu, Pei-Ying, et al.
Publicado: (2017)

Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors—In Silico Activity Prediction
por: Dąbrowska, Aleksandra, et al.
Publicado: (2018)

Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications
por: Espinasse, Adeline, et al.
Publicado: (2020)

Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC–MS
por: Thompson, Beth, et al.
Publicado: (2023)

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review
por: Rutherford, George W., et al.
Publicado: (2016)

New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity
por: Krečmerová, Marcela, et al.
Publicado: (2017)

Development of triazine non-nucleoside reverse transcriptase inhibitors for microbicidal applications
por: Ariën, Kevin K, et al.
Publicado: (2011)

Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
por: Marfatia, Yogesh S., et al.
Publicado: (2014)

Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
por: Vanangamudi, Murugesan, et al.
Publicado: (2023)

Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
por: Schauer, Grant, et al.
Publicado: (2013)

Global Conformational Dynamics of HIV-1 Reverse Transcriptase Bound to Non-Nucleoside Inhibitors
por: Wright, David W., et al.
Publicado: (2012)

Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV
por: Himmel, Daniel M., et al.
Publicado: (2020)

Parallel Response of Myofibrillar Contraction and Relaxation to Four Different Nucleoside Triphosphates
por: Weber, A.
Publicado: (1969)

Substrate mimicry: HIV-1 reverse transcriptase recognizes 6-modified-3′-azido-2′,3′-dideoxyguanosine-5′-triphosphates as adenosine analogs
por: Herman, Brian D., et al.
Publicado: (2012)

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
por: Kennedy, Edward M., et al.
Publicado: (2010)

The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
por: Garforth, Scott J., et al.
Publicado: (2014)

Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
por: Petrou, Anthi, et al.
Publicado: (2019)

Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors
por: BHARDWAJ, Nivedita, et al.
Publicado: (2020)

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
por: De Francesco, Davide, et al.
Publicado: (2021)

The structure of FIV reverse transcriptase and its implications for non-nucleoside inhibitor resistance
por: Galilee, Meytal, et al.
Publicado: (2018)

Nucleoside Analog Reverse-Transcriptase Inhibitors in Membrane Environment: Molecular Dynamics Simulations
por: Stachowicz-Kuśnierz, Anna, et al.
Publicado: (2023)

APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
por: Dwivedi, Richa, et al.
Publicado: (2022)

Nucleoside Triphosphates — Building Blocks for the Modification of Nucleic Acids
por: Hollenstein, Marcel
Publicado: (2012)

The role of nucleoside triphosphate hydrolase metallochaperones in making metalloenzymes
por: Vaccaro, Francesca A, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides
por: McGuigan, Christopher, et al.
Publicado: (2013)

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
por: Pradere, Ugo, et al.
Publicado: (2014)

Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018)

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
por: Reuman, Elizabeth C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5e6jhkbgo08uoil83fpah0g0f0